The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer

par Tejani, Mohamedtaki A, Cohen, Roger B, Mehra, Ranee
Publié 2010

Relationships between personal attitudes about death and communication with terminally ill patients: How oncology clinicians grapple with mortality

par Rodenbach, Rachel A., Rodenbach, Kyle E., Tejani, Mohamedtaki A., Epstein, Ronald M.
Publié dans Patient Educ Couns (2015)

Head and Neck Sarcomas: A Comprehensive Cancer Center Experience

par Tejani, Mohamedtaki A., Galloway, Thomas J., Lango, Miriam, Ridge, John A., von Mehren, Margaret
Publié 2013

Short course radiation therapy for rectal cancer in the elderly: can radical surgery be avoided?

par Cummings, Michael A., Usuki, Kenneth Y., Fleming, Fergal J., Tejani, Mohamedtaki A., Katz, Alan W.
Publié dans J Gastrointest Oncol (2019)

Anticipatory nausea and vomiting due to chemotherapy

par Kamen, Charles, Tejani, Mohamedtaki A., Chandwani, Kavita, Janelsins, Michelle, Peoples, Anita R., Roscoe, Joseph A., Morrow, Gary R.
Publié 2013

Opportunities for cannabis in supportive care in cancer

par Kleckner, Amber S., Kleckner, Ian R., Kamen, Charles S., Tejani, Mohamedtaki A., Janelsins, Michelle C., Morrow, Gary R., Peppone, Luke J.
Publié dans Ther Adv Med Oncol (2019)

Wireless transcutaneous electrical nerve stimulation device for chemotherapy-induced peripheral neuropathy: An open-label feasibility study

par Gewandter, Jennifer S., Chaudari, Jenna, Ibegbu, Chinazom, Kitt, Rachel, Serventi, Jennifer, Burke, Joy, Culakova, Eva, Kolb, Noah, Sluka, Kathleen A., Tejani, Mohamedtaki A., Mohile, Nimish A.
Publié dans Support Care Cancer (2018)

Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma

par Mohamed, Mostafa, Katz, Alan W., Tejani, Mohamedtaki A., Sharma, Ashwani K., Kashyap, Randeep, Noel, Marcus S., Qiu, Haoming, Hezel, Aram F., Ramaraju, Gopal A., Dokus, M. Katherine, Orloff, Mark S.
Publié dans Adv Radiat Oncol (2015)

Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation

par Probst, Christian P, Becerra, Adan Z, Aquina, Christopher T, Tejani, Mohamedtaki A, Wexner, Steven D, Garcia-Aguilar, Julio, Remzi, Feza H, Dietz, David W, Monson, John RT, Fleming, Fergal J
Publié dans J Am Coll Surg (2015)

A Phase Ib, Open‐Label Study of Dalantercept, an Activin Receptor‐Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma

par Abou‐Alfa, Ghassan K., Miksad, Rebecca A., Tejani, Mohamedtaki A., Williamson, Stephen, Gutierrez, Martin E., Olowokure, Olugbenga O., Sharma, Manish R., El Dika, Imane, Sherman, Matthew L., Pandya, Shuchi S.
Publié dans Oncologist (2018)

The impact of age on complications, survival, and cause of death following colon cancer surgery

par Aquina, Christopher T, Mohile, Supriya G, Tejani, Mohamedtaki A, Becerra, Adan Z, Xu, Zhaomin, Hensley, Bradley J, Arsalani-Zadeh, Reza, Boscoe, Francis P, Schymura, Maria J, Noyes, Katia, Monson, John RT, Fleming, Fergal J
Publié dans Br J Cancer (2017)

The social and behavioral influences (SBI) study: study design and rationale for studying the effects of race and activation on cancer pain management

par Elias, Cezanne M., Shields, Cleveland G., Griggs, Jennifer J., Fiscella, Kevin, Christ, Sharon L., Colbert, Joseph, Henry, Stephen G., Hoh, Beth G., Hunte, Haslyn E. R., Marshall, Mary, Mohile, Supriya Gupta, Plumb, Sandy, Tejani, Mohamedtaki A., Venuti, Alison, Epstein, Ronald M.
Publié dans BMC Cancer (2017)

The Influence of Patient Race and Activation on Pain Management in Advanced Lung Cancer: a Randomized Field Experiment

par Shields, Cleveland G., Griggs, Jennifer J., Fiscella, Kevin, Elias, Cezanne M., Christ, Sharon L., Colbert, Joseph, Henry, Stephen G., Hoh, Beth G., Hunte, Haslyn E. R., Marshall, Mary, Mohile, Supriya Gupta, Plumb, Sandy, Tejani, Mohamedtaki A., Venuti, Alison, Epstein, Ronald M.
Publié dans J Gen Intern Med (2019)

Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy: SWOG S1115 Study Randomized Clinical Trial

par Chung, Vincent, McDonough, Shannon, Philip, Philip A., Cardin, Dana, Wang-Gillam, Andrea, Hui, Laifong, Tejani, Mohamedtaki A., Seery, Tara E., Dy, Irene A., Baghdadi, Tareq Al, Hendifar, Andrew E., Doyle, L. Austin, Lowy, Andrew M., Guthrie, Katherine A., Blanke, Charles D., Hochster, Howard S.
Publié dans JAMA Oncol (2017)

Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, dou...

par Catenacci, Daniel V T, Tebbutt, Niall C, Davidenko, Irina, Murad, André M, Al-Batran, Salah-Eddin, Ilson, David H, Tjulandin, Sergei, Gotovkin, Evengy, Karaszewska, Boguslawa, Bondarenko, Igor, Tejani, Mohamedtaki A, Udrea, Anghel A, Tehfe, Mustapha, De Vita, Ferdinando, Turkington, Cheryl, Tang, Rui, Ang, Agnes, Zhang, Yilong, Hoang, Tien, Sidhu, Roger, Cunningham, David
Publié dans Lancet Oncol (2017)